Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients

NCT00577993 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Fludarabine
DRUG: Novantrone
DRUG: Decadron
DRUG: Rituximab
DRUG: Interferon
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Bleomycin
DRUG: Cyclophosphamide
DRUG: Etoposide
DRUG: Cisplatin
DRUG: Ara-C
DRUG: Methyl-Prednisolone
DRUG: Procarbazine
DRUG: Prednisone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]